These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 1874490)

  • 1. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
    Fisher RL; Hofmann AF; Converse JL; Rossi SS; Lan SP
    Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
    Grundy SM; Lan SP; Lachin J
    J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of lethocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine, and their sulfates.
    Cowen AE; Korman MG; Hofmann AF; Cass OW
    Gastroenterology; 1975 Jul; 69(1):59-66. PubMed ID: 1150035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sulfation of lithocholate in patients with cholesterol gallstones during chenodeoxycholate treatment.
    Stiehl A; Raedsch R; Kommerell B
    Digestion; 1975; 12(2):105-10. PubMed ID: 1158064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithocholate metabolism during chemotherapy for gallstone dissolution. 2. Absorption and sulphation.
    Allan RN; Thistle JL; Hofmann AF
    Gut; 1976 Jun; 17(6):413-9. PubMed ID: 955496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical epidemiology of gallbladder cancer.
    Strom BL; Soloway RD; Rios-Dalenz J; Rodriguez-Martinez HA; West SL; Kinman JL; Crowther RS; Taylor D; Polansky M; Berlin JA
    Hepatology; 1996 Jun; 23(6):1402-11. PubMed ID: 8675157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients.
    LaRusso NF; Hoffman NE; Hofmann AF; Northfield TC; Thistle JL
    Gastroenterology; 1975 Dec; 69(6):1301-14. PubMed ID: 1193329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfation and renal excretion of bile salts in patients with cirrhosis of the liver.
    Stiehl A; Earnest DL; Admirant WH
    Gastroenterology; 1975 Mar; 68(3):534-44. PubMed ID: 1112455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative measurement of lithocholic acid compounds in bile from patients with gallstones, before and during treatment with chenodeoxycholic acid.
    Arnfred T; Pedersen L
    Scand J Gastroenterol; 1976; 11(5):497-504. PubMed ID: 959764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of lithocholate in healthy man. II. Enterohepatic circulation.
    Cowen AE; Korman MG; Hofmann AF; Cass OW; Coffin SB
    Gastroenterology; 1975 Jul; 69(1):67-76. PubMed ID: 1097294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids.
    Rossi SS; Converse JL; Hofmann AF
    J Lipid Res; 1987 May; 28(5):589-95. PubMed ID: 3598401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural evidence of intrahepatic cholestasis before and after chenodeoxycholic acid therapy in patients with cholelithiasis: the national cooperative gallstone study.
    Phillips MJ; Fisher RL; Anderson DW; Lan SP; Lachin JM; Boyer JL
    Hepatology; 1983; 3(2):209-20. PubMed ID: 6832711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.
    Bazzoli F; Fromm H; Sarva RP; Sembrat RF; Ceryak S
    Gastroenterology; 1982 Oct; 83(4):753-60. PubMed ID: 7106506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of lithocholate in healthy man. III. Plasma disappearance of radioactivity after intravenous injection of labeled lithocholate and its derivatives.
    Cowen AE; Korman MG; Hofmann AF; Thomas PJ
    Gastroenterology; 1975 Jul; 69(1):77-82. PubMed ID: 1150037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates.
    Allan RN; Thistle JL; Hofmann AF; Carter JA; Yu PY
    Gut; 1976 Jun; 17(6):405-12. PubMed ID: 955495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and effect of 7-oxo-lithocholic acid 3-sulfate on bile flow and biliary lipid secretion in rats.
    Yamashita H; Setchell KD
    Hepatology; 1994 Sep; 20(3):663-71. PubMed ID: 8076924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxic effect of bile acids in inflammatory bowel disease.
    Dew MJ; van Berge Henegouwen GP; Huybregts AW; Allan RN
    Gastroenterology; 1980 Jun; 78(6):1393-401. PubMed ID: 7372059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The profile of bile acids and their sulfate metabolites in human urine and serum.
    Bathena SP; Mukherjee S; Olivera M; Alnouti Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():53-62. PubMed ID: 24212143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.